Nanosensor Chemical Cytometry: Advances and Opportunities in Cellular Therapy and Precision Medicine

• Published in: ACS measurement science au 2023-12, Vol.3 (6), p.393-403
• Main Authors: Song, Youngho, Tian, Changyu, Lee, Yullim, Yoon, Minyeong, Yoon, Sang Eun, Cho, Soo-Yeon
• Format: Article
• Language: English
• ISSN: 2694-250X; 2694-250X
• DOI: 10.1021/acsmeasuresciau.3c00038

With the definition of therapeutics now encompassing transplanted or engineered cells and their molecular products, there is a growing scientific necessity for analytics to understand this new category of drugs. This Perspective highlights the recent development of new measurement science on label-free single cell analysis, nanosensor chemical cytometry (NCC), and their potential for cellular therapeutics and precision medicine. NCC is based on microfluidics integrated with fluorescent nanosensor arrays utilizing the optical lensing effect of a single cell to real-time extract molecular properties and correlate them with physical attributes of single cells. This new class of cytometry can quantify the heterogeneity of the multivariate physicochemical attributes of the cell populations in a completely label-free and nondestructive way and, thus, suggest the vein-to-vein conditions for the safe therapeutic applications. After the introduction of the NCC technology, we suggest the technological development roadmap for the maturation of the new field: from the sensor/chip design perspective to the system/software development level based on hardware automation and deep learning data analytics. The advancement of this new single cell sensing technology is anticipated to aid rich and multivariate single cell data setting and support safe and reliable cellular therapeutics. This new measurement science can lead to data-driven personalized precision medicine.